Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-25-014310
Filing Date
2025-02-14
Accepted
2025-02-14 17:13:51
Documents
18

Document Format Files

Seq Description Document Type Size
1 424B3 tm2430195-17_424b3.htm 424B3 10807822
2 GRAPHIC lg_caratmtherap-4c.jpg GRAPHIC 20477
3 GRAPHIC fc_pipeline-4clr.jpg GRAPHIC 43142
4 GRAPHIC fc_canonical-4clr.jpg GRAPHIC 70761
5 GRAPHIC fc_dualmechanism-4clr.jpg GRAPHIC 99307
6 GRAPHIC fc_centralcatalyst-4clr.jpg GRAPHIC 82589
7 GRAPHIC fc_currentpipeline-4clr.jpg GRAPHIC 42898
8 GRAPHIC fc_ipfaffected-4clr.jpg GRAPHIC 73450
9 GRAPHIC fc_lungfibrosis-4clr.jpg GRAPHIC 84531
10 GRAPHIC bc_bothextrinsic-4clr.jpg GRAPHIC 101044
11 GRAPHIC bc_dosedepen-4clr.jpg GRAPHIC 84572
12 GRAPHIC fc_evaluating-4clr.jpg GRAPHIC 50945
13 GRAPHIC fc_mousemodel-4clr.jpg GRAPHIC 78860
14 GRAPHIC fc_engrafted-4clr.jpg GRAPHIC 53142
15 GRAPHIC lc_treatment-4clr.jpg GRAPHIC 63705
16 GRAPHIC fc_clinicaltrial-4clr.jpg GRAPHIC 90780
17 GRAPHIC px_25caraproxy1pg01-bw.jpg GRAPHIC 305866
18 GRAPHIC px_25caraproxy1pg02-bw.jpg GRAPHIC 231322
  Complete submission text file 0001104659-25-014310.txt   12942941
Mailing Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901
Business Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-283900 | Film No.: 25630863
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)